<DOC>
	<DOCNO>NCT00730704</DOCNO>
	<brief_summary>Worldwide cervical cancer remain major cause mortality among woman . It estimate year 490,000 woman diagnose cervical cancer 270,000 die disease . While implementation widespread screening program reduce burden cervical cancer , large percentage population still remain unscreened underscreened . It recognize human papillomavirus ( HPV ) necessary precursor development cervical cancer . The first vaccine prevent HPV recently approve Food Drug Administration available doctor office . Despite availability safe effective mean prevention cervical cancer , widespread implementation vaccination extremely difficult . Several potential issue limit development widespread HPV vaccination program , include cultural religious belief , limitation practicality administer vaccine . The overall goal work improve access preventive strategy cervical cancer . In proposal examine strategy HPV vaccination woman give birth . We believe HPV vaccination woman associate high level patient satisfaction acceptance . If successful , strategy could play major role advance acceptance implementation HPV vaccination United States .</brief_summary>
	<brief_title>Acceptance Human Papillomavirus Vaccination Postpartum Women</brief_title>
	<detailed_description>Primary Objective 1 . To estimate compliance HPV vaccine series initiate postpartum woman . Secondary Objectives 1 . To determine patient acceptance satisfaction HPV vaccination administer postpartum period . 2 . To determine predictor compliance HPV vaccination series .</detailed_description>
	<mesh_term>Papilloma</mesh_term>
	<criteria>Age 1826 year . Patients hospitalized postpartum period normal spontaneous vaginal delivery , assist vaginal delivery Cesarean section . Patients deliver singleton fetus multiple gestation eligible participation . Patients may deliver gestational age 3244 week . Patients must sign informed consent . Patients must meet preentry criterion . Patients breast feed eligible participation . Patients must obstetrician see obstetric care plan followup postpartum period . Age &lt; 18 &gt; 26 year . Patients hemophilia , bleed disorder thrombocytopenia ( platelet &lt; 100,000/ul ) . Patients receive active anticoagulant therapy warfarin , heparin low molecular weight heparin . Pregnancy plan pregnancy within next 6 month . Ongoing bacteremia , endomyometritis serious febrile illness . Hypersensitivity yeast , aluminum vaccine component . Prior vaccination prophylactic HPV vaccine ( single multiple dos ) . Patients deliver nonviable infant infant severe congenital malformation . Patients plan follow postpartum local obstetrician maternal fetal medicine specialist . Patients unwilling receive subsequent dose HPV vaccine .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Human Papilloma Virus vaccine</keyword>
	<keyword>HPV</keyword>
	<keyword>Gardasil</keyword>
	<keyword>Post partum</keyword>
</DOC>